Magali Suzanne

Group leader at the CBI in Toulouse #droso #cell biology #morphogenesis #apoptosis

[@antabio @antabio]

Our 2 new collaborative papers on @antabio's clinical candidate ANT2681, a potent #NDM inhibitor in combination w/ meropenem for treating #MBL #CRE infections👇

1⃣SAR (ACS Infect. Dis, w/@unisiena): https://t.co/QYd3glCies

2⃣PKPD (AAC, w/@LivUni): https://t.co/pvQdfk5zTf

#AMR

[Marc Lemonnier @MLantabio]

The SAR and PKPD of ANT2681-MEM, @antabio's QIDP-designated clinical candidate for treating NDM-CRE infections, published in two different papers in collaboration with @LivUni & @unisiena, respectively. https://t.co/G118y4y4O8

[@antabio @antabio]

Antabio’s CF program funded by CARB-X highlighted
in Forbes #cysticfibrosis @CARB_X @danadovey
https://t.co/16HrJYwfkK

[Marc Lemonnier @MLantabio]

Antabio’s CF program funded by CARB-X highlighted
in Forbes #cysticfibrosis @CARB_X @antabio https://t.co/hy3Kw1Yjn7

[Marc Lemonnier @MLantabio]

Antabio SAS advances cystic fibrosis programme - https://t.co/t0Ted0VMPc via @EuroBiotechNews

[@antabio @antabio]

Antabio reçoit 4 millions d’Euros de @CARB_X pour poursuivre le développement de son nouveau traitement des infections à Pseudomonas chez les patients atteints de mucoviscidose. https://t.co/RF0sa6HU9k #mucoviscidose #antibiorésistance

[Marc Lemonnier @MLantabio]

Thrilled to announce the successful transition to the next stage of our Pseudomonas Elastase Inhibitor program in collaboration with @CARB_X! #cysticfibrosis #AMR https://t.co/TtmylzIj2V

[Ⓙⓐⓥⓘⓔⓡ🇵🇸 Ⓑⓤⓒⓔⓣⓐ🇺🇦 @JavierBuceta]

Our paper about tissue elongation due to the interplay between signaling and cellular mechanics is now available at BioRxiv

Samira Anbari did a great job!!! She will be looking for a postdoc soon...

@SamiraAnbari
@_JamesSharpe

https://t.co/M1RohhOHsD

[Marc Lemonnier @MLantabio]

Today I moarn the death of #MargaritaSalas, one of the greatest spanish scientists and a true source of inspiration for all molecular geneticists in the world. She worked in the lab until her very last days. Your legacy is enormous, Madame, as is our gratitude to you

[Suzanne's lab @suzanne_team]

Our new paper describing a new role for the nucleus as an actor in force generation during morphogenesis is online in @Dev_Cell. Congratulations to Arnaud and Mégane for their fantastic work @CbiToulouse !!
https://t.co/LwV452wJ9j

[Xavier Trepat @XavierTrepat]

📢Launching the @Mechanocontrol Summer School on #Mechanobiology of Breast Cancer. From 17-20 of September 2019 in La #Cerdanya, at the heart of the Catalan Pyrenees 🌲, north of #Barcelona. Registration soon. 🔝 speakers! 🔥topics! More info: https://t.co/DnbEZ5LPN5

[CNRS Biologie @CNRSbiologie]

#TalentsCNRS 🏅| Découvrez le portrait #vidéo de Nicolas Minc @MincLab, chercheur en #biophysique à l'#InstitutJacquesMonod, lauréat de la médaille de bronze du @CNRS 2018

▶️ https://t.co/W6t8vTPlF3

[Cedric Maurange @CMaurange]

Our latest @MaurangeLab ! And thanks @PLOSBiology for excellent editorial management

[Steph Vassilopoulos @Biosdfp]

Check out latest @DavidGDrubin lab cool paper on how type 1 myosins anchor actin assembly during clathrin-mediated endocytosis in @JCellBiol https://t.co/pWN8TYnOC4.

[Xavier Trepat @XavierTrepat]

#CellMech2019 The biennial event in cell mechanics you can’t miss. June 3-6, 2019 in Milan. Co-chaired by Nils Gauthier and Virgille Viasnoff. https://t.co/U9nx0fxfJx

[Tanentzapf Lab @TanentzapfLab]

This is great. I wish more reviewers did this.

[Mechanobiology Institute @MBIsg]

Dystrophin as a shock absorber: A study @MBIsg @NUSingapore @UMNews published @acsnano shows how stochastic unfolding & refolding of spectrin repeats in dystrophin central domain helps in buffering forces during muscle contraction. https://t.co/INGgdU5Iyx #musculardystrophy

[Xavier Trepat @XavierTrepat]

Ultraflexible Nanowire Array for Label- and Distortion-Free Cellular Force Tracking
https://t.co/LquM4zQ60s

[julien vermot @julien_vermot]

Mechanosignalling via integrins directs fate decisions of pancreatic progenitors | Nature https://t.co/OkPuRfmH6F